Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 7,410 | 316,192 | 17,193 | 20,116 | 24,208 |
| Gross Profit | 7,410 | 316,192 | 17,193 | 20,116 | 24,208 |
| Operating Expenses | 111,542 | 183,334 | 125,460 | 122,264 | 123,136 |
| Operating Income | -104,132 | 132,858 | -108,267 | -102,148 | -98,928 |
| Other Income | 5,463 | 11,305 | 12,179 | 19,372 | 2,468 |
| Pre-tax Income | -98,669 | 144,163 | -96,088 | -82,776 | -96,460 |
| Net Income Continuous | -98,669 | 142,797 | -96,088 | -82,776 | -96,460 |
| Net Income | $-98,669 | $142,797 | $-96,088 | $-82,776 | $-96,460 |
| EPS Basic Total Ops | -1.21 | 1.91 | -1.22 | -1.08 | -1.33 |
| EPS Basic Continuous Ops | -1.21 | 1.92 | -1.22 | -1.08 | -1.33 |
| EPS Diluted Total Ops | -1.21 | 1.91 | -1.22 | -1.08 | -1.33 |
| EPS Diluted Continuous Ops | -1.21 | 1.92 | -1.22 | -1.08 | -1.33 |
| EPS Diluted Before Non-Recurring Items | N/A | 1.73 | -1.22 | -1.08 | -1.33 |
| EBITDA(a) | $-105,277 | $130,866 | $-110,964 | $-104,905 | $-101,213 |